Shan‐Liang Sun
-
- Multiple Myeloma Research and Treatments 3
-
- Protein Degradation and Inhibitors 5
- Ubiquitin and proteasome pathways 4
- Epigenetics and DNA Methylation 4
-
- Chronic Lymphocytic Leukemia Research 3
-
- Computational Drug Discovery Methods 4
-
- Microbial Natural Products and Biosynthesis 3
-
- Microtubule and mitosis dynamics 3
- Co-authors
- Nian‐Guang LiRob LeursIwan J. P. de EschChris de GraafMartine J. SmitMarta ArimontZhi‐Hao ShiTian‐Yuan Fan
- Journals
- SHILAP Revista de lepidopterología (1 paper)International Journal of Molecular Sciences (1 paper)Journal of Medicinal Chemistry (5 papers)
- Partner nations
- ChinaNetherlandsUnited States
In The Last Decade
Shan‐Liang Sun
34 papers receiving 460 citations
Peers
Comparison fields: 5 of 74
- Hematology 52
- Cancer Research 69
- Molecular Biology 311
- Oncology 117
- Genetics 40
Countries citing papers authored by Shan‐Liang Sun
This map shows the geographic impact of Shan‐Liang Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan‐Liang Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan‐Liang Sun more than expected).
Fields of papers citing papers by Shan‐Liang Sun
This network shows the impact of papers produced by Shan‐Liang Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan‐Liang Sun. The network helps show where Shan‐Liang Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shan‐Liang Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 9 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 16 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 17 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2024 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2023 | 22 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 18 | |
| 16 | 2023 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2022 | 24 | |
| 19 | 2019 | 14 | |
| 20 | 2018 | 11 |
About Shan‐Liang Sun
Shan‐Liang Sun is a scholar working on Genetics, Hematology and Oncology, having authored 37 papers that have together received 465 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (4 papers), Computational Drug Discovery Methods (4 papers), Epigenetics and DNA Methylation (4 papers), Microbial Natural Products and Biosynthesis (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Microtubule and mitosis dynamics (3 papers). The work is most often cited by research in Hematology (52 citations), Cancer Research (69 citations) and Molecular Biology (311 citations). Shan‐Liang Sun has collaborated with scholars based in China, Netherlands and United States. Frequent co-authors include Nian‐Guang Li, Rob Leurs, Iwan J. P. de Esch, Chris de Graaf, Martine J. Smit, Marta Arimont, Zhi‐Hao Shi, Tian‐Yuan Fan, Yue Zhong and Min Chen. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.